Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Calvo

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Atherosclerosis|November 17, 2021
Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA studyAndrea Sánchez-Ramos, Carlos Fernández-Labandera, Antonio J Vallejo-Vaz, et al.
BMC Medical Genetics|May 1, 2010
Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-studyMaría-José Ariza, Miguel-Angel Sánchez-Chaparro, Francisco-Javier Barón, et al.
NPJ Vaccines|August 15, 2020
A protective bivalent vaccine against Rift Valley fever and bluetongueEva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, et al.
The Journal of Cell Biology|February 4, 2025
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progressionDiogjena Katerina Prifti, Annie Lauzier, Chantal Garand, et al.
Cirugia Espanola|April 13, 2013
[Pre-surgical period and non-work-related sickness absence due to inguinal hernia]Montserrat Ruiz-Moraga, Carlos Catalina-Romero, Paloma Martínez-Muñoz, et al.
Frontiers in Public Health|November 16, 2020
COVID-19 and Sick Leave: An Analysis of the Ibermutua Cohort of Over 1,651,305 Spanish Workers in the First Trimester of 2020Eva Calvo-Bonacho, Carlos Catalina-Romero, Carlos Fernández-Labandera, et al.
European Journal of Preventive Cardiology|April 2, 2015
Comparison of application of different methods to estimate lifetime cardiovascular riskCarlos Brotons, Eva Calvo-Bonacho, Irene Moral, et al.
European Journal of Preventive Cardiology|July 26, 2014
Factors influencing return-to-work after cerebrovascular disease: the importance of previous cardiovascular riskCarlos Catalina-Romero, Luis Miguel Ruilope, Miguel Angel Sánchez-Chaparro, et al.
Vaccines|July 3, 2020
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue VirusSergio Utrilla-Trigo, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, et al.
Journal of Virology|November 17, 2021
The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2<sub>1-180</sub>) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus ChallengeSergio Utrilla-Trigo, Luis Jiménez-Cabello, Eva Calvo-Pinilla, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Atherosclerosis|November 17, 2021
Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA studyAndrea Sánchez-Ramos, Carlos Fernández-Labandera, Antonio J Vallejo-Vaz, et al.
BMC Medical Genetics|May 1, 2010
Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-studyMaría-José Ariza, Miguel-Angel Sánchez-Chaparro, Francisco-Javier Barón, et al.
NPJ Vaccines|August 15, 2020
A protective bivalent vaccine against Rift Valley fever and bluetongueEva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, et al.
The Journal of Cell Biology|February 4, 2025
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progressionDiogjena Katerina Prifti, Annie Lauzier, Chantal Garand, et al.
Cirugia Espanola|April 13, 2013
[Pre-surgical period and non-work-related sickness absence due to inguinal hernia]Montserrat Ruiz-Moraga, Carlos Catalina-Romero, Paloma Martínez-Muñoz, et al.
Frontiers in Public Health|November 16, 2020
COVID-19 and Sick Leave: An Analysis of the Ibermutua Cohort of Over 1,651,305 Spanish Workers in the First Trimester of 2020Eva Calvo-Bonacho, Carlos Catalina-Romero, Carlos Fernández-Labandera, et al.
European Journal of Preventive Cardiology|April 2, 2015
Comparison of application of different methods to estimate lifetime cardiovascular riskCarlos Brotons, Eva Calvo-Bonacho, Irene Moral, et al.
European Journal of Preventive Cardiology|July 26, 2014
Factors influencing return-to-work after cerebrovascular disease: the importance of previous cardiovascular riskCarlos Catalina-Romero, Luis Miguel Ruilope, Miguel Angel Sánchez-Chaparro, et al.
Vaccines|July 3, 2020
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue VirusSergio Utrilla-Trigo, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, et al.
Journal of Virology|November 17, 2021
The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2<sub>1-180</sub>) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus ChallengeSergio Utrilla-Trigo, Luis Jiménez-Cabello, Eva Calvo-Pinilla, et al.
Pageof 14